Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/89711
DC Field | Value | Language |
---|---|---|
dc.contributor | School of Optometry | - |
dc.creator | Jong, M | en_US |
dc.creator | Jonas, JB | en_US |
dc.creator | Wolffsohn, JS | en_US |
dc.creator | Berntsen, DA | en_US |
dc.creator | Cho, P | en_US |
dc.creator | Clarkson-Townsend, D | en_US |
dc.creator | Flitcroft, DI | en_US |
dc.creator | Gifford, KL | en_US |
dc.creator | Haarman, AEG | en_US |
dc.creator | Pardue, MT | en_US |
dc.creator | Richdale, K | en_US |
dc.creator | Sankaridurg, P | en_US |
dc.creator | Tedja, MS | en_US |
dc.creator | Wildsoet, CF | en_US |
dc.creator | Bailey-Wilson, JE | en_US |
dc.creator | Guggenheim, JA | en_US |
dc.creator | Hammond, CJ | en_US |
dc.creator | Kaprio, J | en_US |
dc.creator | MacGregor, S | en_US |
dc.creator | Mackey, DA | en_US |
dc.creator | Musolf, AM | en_US |
dc.creator | Klaver, CCW | en_US |
dc.creator | Verhoeven, VJM | en_US |
dc.creator | Vitart, V | en_US |
dc.creator | Smith, EL | en_US |
dc.date.accessioned | 2021-05-05T04:56:57Z | - |
dc.date.available | 2021-05-05T04:56:57Z | - |
dc.identifier.issn | 0146-0404 | en_US |
dc.identifier.uri | http://hdl.handle.net/10397/89711 | - |
dc.language.iso | en | en_US |
dc.publisher | Association for Research in Vision and Ophthalmology | en_US |
dc.rights | Copyright 2021 The Authors | en_US |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. (http://creativecommons.org/licenses/by-nc-nd/4.0) | en_US |
dc.subject | Myopia | en_US |
dc.subject | Classification | en_US |
dc.subject | Definitions | en_US |
dc.subject | High myopia | en_US |
dc.subject | Pathologic myopia | en_US |
dc.subject | Genetics, emmetropization | en_US |
dc.subject | Interventions | en_US |
dc.subject | Atropine | en_US |
dc.subject | Contact lenses | en_US |
dc.subject | Spectacles | en_US |
dc.subject | Orthokeratology, management guidelines | en_US |
dc.subject | Clinical trials | en_US |
dc.subject | Axial length | en_US |
dc.subject | Cycloplegia | en_US |
dc.title | IMI 2021 yearly digest | en_US |
dc.type | Journal/Magazine Article | en_US |
dc.identifier.spage | 1 | en_US |
dc.identifier.epage | 21 | en_US |
dc.identifier.volume | 62 | en_US |
dc.identifier.issue | 5 | en_US |
dc.identifier.doi | 10.1167/iovs.62.5.7 | en_US |
dcterms.abstract | Purpose: The International Myopia Institute (IMI) Yearly Digest highlights new research considered to be of importance since the publication of the first series of IMI white papers. | - |
dcterms.abstract | Methods: A literature search was conducted for articles on myopia between 2019 and mid-2020 to inform definitions and classifications, experimental models, genetics, interventions, clinical trials, and clinical management. Conference abstracts from key meetings in the same period were also considered. | - |
dcterms.abstract | Results: One thousand articles on myopia have been published between 2019 and mid-2020. Key advances include the use of the definition of premyopia in studies currently under way to test interventions in myopia, new definitions in the field of pathologic myopia, the role of new pharmacologic treatments in experimental models such as intraocular pressure–lowering latanoprost, a large meta-analysis of refractive error identifying 336 new genetic loci, new clinical interventions such as the defocus incorporated multisegment spectacles and combination therapy with low-dose atropine and orthokeratology (OK), normative standards in refractive error, the ethical dilemma of a placebo control group when myopia control treatments are established, reporting the physical metric of myopia reduction versus a percentage reduction, comparison of the risk of pediatric OK wear with risk of vision impairment in myopia, the justification of preventing myopic and axial length increase versus quality of life, and future vision loss. | - |
dcterms.abstract | Conclusions: Large amounts of research in myopia have been published since the IMI 2019 white papers were released. The yearly digest serves to highlight the latest research and advances in myopia. | - |
dcterms.accessRights | open access | - |
dcterms.bibliographicCitation | Investigative ophthalmology and visual science, Apr. 2021, v. 62, no.5, 7, p. 1-21 | en_US |
dcterms.isPartOf | Investigative ophthalmology and visual science | en_US |
dcterms.issued | 2021-04 | - |
dc.identifier.eissn | 1552-5783 | en_US |
dc.identifier.artn | 7 | en_US |
dc.description.validate | 202105 bcwh | - |
dc.description.oa | Version of Record | - |
dc.identifier.FolderNumber | a0879-n01 | - |
dc.description.fundingSource | Others | - |
dc.description.fundingText | Funding acknowledgements: Supported by the International Myopia Institute. The publication costs of the International Myopia Institute reports were supported by donations from the Brien Holden Vision Institute, Carl Zeiss Vision, CooperVision, Essilor, and Alcon. | - |
dc.description.pubStatus | Published | - |
Appears in Collections: | Journal/Magazine Article |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
i1552-5783-62-5-7_1619605405.43593.pdf | 954.89 kB | Adobe PDF | View/Open |
Page views
85
Last Week
0
0
Last month
Citations as of Apr 14, 2024
Downloads
15
Citations as of Apr 14, 2024
SCOPUSTM
Citations
39
Citations as of Apr 19, 2024
WEB OF SCIENCETM
Citations
35
Citations as of Apr 18, 2024
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.